Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07278778

A Pilot Study of Cancer Care Companion, An Electronic Health Record Tool to Improve Information Exchange and Self-Management in Pediatric Cancer

Led by Washington University School of Medicine · Updated on 2026-02-06

40

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

W

Washington University School of Medicine

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Effective communication between healthcare providers and parents is essential for optimal care of children with cancer. This research evaluates a communication tool called Cancer Care Companion, designed to be used through electronic health records (EHR). The study aims to assess how acceptable, appropriate, and feasible this tool is for parents of pediatric cancer patients. Parents will have access to the Cancer Care Companion via Epic MyChart for a period of 3 months. During this time, they will complete educational modules, check-in surveys, and may choose to receive patient stories. The program includes 13 educational tasks, 7 surveys, and 5 patient stories available upon request, with ongoing access to revisit content during the intervention. Participants will complete surveys before and after using the tool and take part in a semi-structured interview after the 3-month period. Researchers will measure outcomes such as tool feasibility, quality of information exchange, trust in physicians, caregiver burden, parental anxiety, communication quality, and perceptions of the tool's usability, usefulness, and barriers. The study is sponsored by Washington University School of Medicine and runs until August 2027.

CONDITIONS

Brief Title

Cancer Care Companion

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Legal guardian of a child diagnosed with cancer within the prior 4 weeks
  • Child plans to receive or currently receives cancer-directed therapy at St. Louis Children's Hospital
  • Parent or legal guardian has internet access via computer or smartphone
  • Speaks and reads English
  • Parent or legal guardian agrees to enroll in Epic MyChart to access a proxy portal for their child
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - Up to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote) to confirm eligibility and assist with MyChart registration

Treatment

Duration - 3 months

Participants use the Cancer Care Companion tool through Epic MyChart for 3 months, completing educational tasks, check-in surveys, and optionally receiving patient stories to support self-management and information exchange.

Participants complete 13 educational tasks, 7 check-in surveys, and up to 5 patient stories during this period

Follow-up

Duration - 1 to 2 weeks immediately post-intervention

Participants complete a semi-structured interview and post-intervention surveys to assess tool feasibility, usability, and impact immediately after the 3-month intervention.

1 interview and 1 survey completion visit (remote or in-person)

Trial Site Locations

Total: 1 location

1

Washington University School of Medicine/Saint Louis Children's Hospital

St Louis, Missouri, United States, 63110

Actively Recruiting

Loading map...

Research Team

B

Bryan A Sisk, MD, MSCI

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Similar Trials

A Hypnosis-based Group Intervention to Improve Quality of Li...

Pediatric Cancer

Actively Recruiting

1 location

Phase I First in Human Study of CBA-1205, Anti-DLK1 Monoclon...

Solid Tumors

Actively Recruiting

5 locations

A Prospective Clinical Cohort Study on Stratified Treatment ...

Rhabdomyosarcoma

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here